Biotech investors interested in seeing more details about these companies and a full list of their related stories can do so by typing the stock ticker symbol into the Stock Quotes box on the right side of the page.Amarin Corporation plc (NASDAQ: AMRN) announced today that it has sent to its shareholders a Notice of the Annual General Meeting of the Company, which will be held on December 21, 2009 in Dublin, Ireland.ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD’s investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534, at the 51st Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, Louisiana, December 5-8, 2009.Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the 21st Annual Piper Jaffray Healthcare Conference on December 1 in New York City.Catalyst Rx, the pharmacy benefit management (PBM) subsidiary of Catalyst Health Solutions, Inc. (NASDAQ: CHSI), announced today that its member-focused Web site, www.CatalystRx.com, won a Platinum award in the Strategic Health Care Communications’ annual eHealthcare Leadership Awards for Best Interactive Site.The clouds of darkness that have been hanging over over CytRx Corporation (NASDAQ:CYTR) may soon be cast aside. CDEX Inc. (OTCBB:CEXI) (www.cdexinc.com) and All Business Machines, Inc. ("ABMI") (www.abmicorp.com) announce that the ValiMed™ MVS (Medication Validation System) and ID2 Meth Scanner™ product lines by CDEX have been placed on the ABMI GSA Contract Schedule.ValiMed MVS puts a technological safety net between the patient and errors made in the compounding of high risk medications and guards against narcotic diversion.MedPro Safety Products, Inc. (OTCBB: MPSP), a pioneer in the development and marketing of passive needlestick injury prevention technology, today reported on the company’s recent progress.NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC (www.terrapinn.com/usaflu).Neogen Corporation (Nasdaq: NEOG) announced today that Richard T. Crowder, Ph.D., was elected to Neogen's Board of Directors at the company's recentannual meeting of shareholders.Origin Agritech Limited (NASDAQ GS: SEED) (“Origin”), a leading technology-focused supplier of crop seeds and agri-biotech research in China, today announced it has received the Bio-safety Certificate from the Ministry of Agriculture as a final approval for commercial approval of the world’s first genetically modified phytase corn.Oncolytics Biotech Inc., (TSX:ONC; NASDAQ:ONCY) announced today that it has closed its previously announced US$12,750,00 offering in which a syndicate of underwriters purchased 4,250,000 units of the Company, each unit comprised of one common share and 0.4 of a common share purchase warrant, at a price of US$3.00 per unit.As part of its drug pipeline Ohr Pharmaceutical (OTCBB:OHRP) is developing a wet AMD (Macular Degeneration) therapy, based on technology acquired from Genaera Liquidating Trust.Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), a specialty pharmaceutical company, today announced it has closed its previously announced public offering of 5,500,000 shares of its common stock at a price of $21.00 per share.TapImmune, Inc. (OTCBB:TPIV) announced that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs and Message Boards. QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report.Walgreens (NYSE, NASDAQ: WAG), the nation’s largest drugstore chain and a leading destination for health and wellness services, today announced the re-launch of Walgreens.com (www.walgreens.com), offering users a variety of new healthy living and product resources, along with expanded yet simplified shopping tools and services.Walgreens (NYSE:WAG)(NASDAQ:WAG) today announced the appointment of two new executives. Kathleen Wilson-Thompson has been named senior vice president and chief human resources officer, and Charles V. Greener has been named to the new position of vice president of corporate affairs and communications.ZOLL Medical Corporation (NasdaqGS: ZOLL) announced today that the LifeVest® wearable defibrillator was discussed in three separate scientific presentations at the American Heart Association 2009 Science Session in Orlando, Florida last week.

EpiCept Corporation (Nasdaq:EPCT) announced a Nasdaq Hearings Panel has granted the Company’s request for continued listing on The Nasdaq Stock Market.

GenVec, Inc. (Nasdaq:GNVC) announced Paul H. Fischer, Ph.D., President and CEO, will present a company overview highlighting recent developments at the Merriman Curhan Ford's 6th Annual Investor Summit on Tuesday, November 10, 2009 at 9:20 am EST at Sofitel Hotel in New York, NY.

Enzon Pharmaceuticals, Inc. (Nasdaq:ENZN) announced its third quarter 2009 financial results. For the three months ended September 30, 2009, Enzon reported a net income of $0.1 million or break-even on a diluted per-share basis, as compared to a net loss of $2.0 million or $0.05 on a diluted per-share basis for the third quarter of 2008.

ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced Jonathan Lewis, MD, PhD, Chief Executive Officer, will present at the 6th Annual Merriman, Curhan, Ford Investor Summit on Tuesday, November 10, 2009 at 12:20 pm ET at the Soffitel Hotel in New York, NY. Dr. Lewis will provide an overview of the Company and its clinical development programs.

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) reported results for the quarter ended September 30, 2009.

Aetna (NYSE:AET) is providing free electronic roster billing for pharmacies and other non-traditional providers to use when submitting claims for the administration of the H1N1 flu vaccine.

Stem Cell Therapy International Inc. (OTC:SCII) and its soon to be subsidiary, Histostem Ltd. of South Korea ("Histostem"), announced they have entered into a definitive agreement for up to a $5 million investment commitment with Socius Life Science Capital Group, LLC.The Company's plan is to have funds available no later than December 31, 2009 and use the proceeds for various growth initiatives, including the launch of its stem cell based facial cream, the initiation of clinical trials, maintaining and advancement of current GMP facility as well as ongoing working capital and general corporate purposes.

NanoLogix, Inc. (OTC:NNLX), announces the company has recently filed BNP™ (BioNanoPore) national patent applications in China, Japan, India, Brazil, Russia and the EU.

Sinovac Biotech Ltd. (NYSE:SVA), a leading developer and provider of vaccines in China, announced it will voluntarily transfer its stock exchange listing from the NYSE Amex to the NASDAQ Global Market.

Solos Endoscopy, Inc. (OTC:SNDY) is pleased to announce the Company has received purchase orders for its MammoView(TM) line of surgical endoscopy instruments from various hospitals under Catholic Health Initiatives, Littleton, CO.

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,612,199 (the ‘199 patent) entitled “Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin”.

Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) announced Robert Perez, EVP and COO, will present on Wednesday, November 18, 2009 at 1:45 p.m. Eastern Time at the Lazard Capital Markets 6th Annual Healthcare Conference at the St Regis Hotel in New York City.

Merck & Co., Inc. (NYSE:MRK) and Schering-Plough Corporation (NYSE:SGP) announced they will complete their merger shortly after 4:00PM ET.

Advanced Cell Technology, Inc. (OTC:CTC) announced its Chief Executive Officer, William Caldwell, IV, presented at the BIO Europe Conference being held in Vienna, Austria.

Catalyst Health Solutions, Inc. (NASDAQ:CHSI), a pharmacy benefit management company, announced its financial results for the third quarter ended September 30, 2009.

Optigenex Inc. (OTC:OPGX), has unveiled a new information web page www.optigenex.com designed to connect with prospective corporate customers and partners in the wellness and personal care industries.

Walgreens (NYSE:WAG) executive vice president and chief financial officer Wade Miquelon will present during the Credit Suisse Annual Healthcare Conference in Phoenix on Thursday, Nov. 12, 2009 at approximately 10 a.m. MST (noon EST).

BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) announced the Company plans to release its financial results for the three and nine months ended September 30, 2009, on Thursday, November 5, 2009 after the close of the market.

BIOLASE Technology, Inc. (NASDAQ:BLTI), the world's leading dental laser company, announced the launch of the Diolase 10™ Diode Laser for therapeutic applications, including temporary pain relief.

Aethlon Medical, Inc. (OTC:AEMD) announced it has initiated a collaborative biomarker discovery program with the Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine and the Sports Legacy Institute (SLI).

ULURU Inc. (NYSE:ULU) announced it has scheduled a conference call to discuss the third quarter ended September 30, 2009 financial results and provide a general business update on Tuesday, November 17, 2009 at 9:00 a.m. Eastern Time.

CNS Response, Inc. (OTC:CNSO) reported the results of a landmark study presented by Charles DeBattista, D.M.H, M.D., at the U.S. Psychiatric and Mental Health Congress.

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,612,199 (the ‘199 patent) entitled “Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin”.

Viriathus Research LLC, an independent research firm, issued an Update Report for Viralytics Limited (OTC: VRACY), a biotechnology company which is developing therapies and drugs for the treatment of cancer in Australia.

Affymax, Inc. (Nasdaq:AFFY) announced the appointment of Hollings C. Renton to the position of chairman of the company’s board of directors effective December 1, 2009.

ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) announced Jonathan Lewis, MD, PhD, Chief Executive Officer, will present at the 6th Annual Merriman, Curhan, Ford Inventor Summit on Tuesday, November 10, 2009 at 12:20 pm ET at the Soffitel Hotel in New York, NY. Dr. Lewis will provide an overview of the Company and its clinical development programs.

Walgreens (NYSE:WAG), the nation’s largest drugstore chain and industry leader with more than 17,000 certified or licensed immunizers, will begin offering H1N1 injectable vaccines at 18 pharmacies throughout Salt Lake County Thursday.

Lannett Company, Inc. (NYSE:LCI), a manufacturer of generic pharmaceuticals, announced the company will release its fiscal 2010 first-quarter financial results on Monday, November 9, 2009.

Catalyst Health Solutions, Inc. (NASDAQ:CHSI), a pharmacy benefit management company, announced its financial results for the third quarter ended September 30, 2009.

SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced Mohammad Azab, M.D., Chief Medical Officer, will present at the Merriman Curhan Ford 6th Annual Investor Summit on Tuesday November 10, 2009 in New York.

Unigene Laboratories, Inc. (OTC:UGNE) will release financial results for the quarter ended September 30, 2009, after the market closes on Monday, November 9, 2009.

Emisphere Technologies, Inc. (OTC:EMIS) announced management will host a conference call to discuss the Company’s financial and operational results for the third quarter ended September 30, 2009 on Monday, November 9, 2009 at 10:00 AM EST.

BioClinica™, Inc. (NASDAQ:BIOC), a global provider of clinical trial services, announced its financial results for the quarter and nine months ended September 30, 2009.

Universal Detection Technology (OTC:UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, announced it is expanding its product catalogue to include a consumer-ready kit for the detection of black mold.

Emdeon® (NYSE:EM), a leading provider of healthcare revenue and payment cycle management solutions, announced its eRx Network® will provide real-time electronic billing solutions to retail pharmacies for the nation's top 25 medical payers in light of the dramatic increase in H1N1 vaccinations being administered by pharmacies.

Phase Forward (NASDAQ:PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its senior vice president and chief financial officer, Chris Menard, and senior vice president of integration and product strategy, Martin Young, will present at the 18th Annual Credit Suisse Healthcare Conference at the Arizona Biltmore Hotel in Phoenix, Arizona.

Medidata Solutions (NASDAQ:MDSO), a leading global provider of hosted clinical development solutions, announced a multi-year contract extension with Shire plc (NASDAQ:SHPGY) for use of Medidata Grants Manager™ and CRO Contractor™ benchmarking and analysis tools for investigator site and contract research organization (CRO) trial budget planning and forecasting.

Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing a novel T-cell therapy for multiple sclerosis (MS), reported financial results for the quarter ended September 30, 2009, and provided details on further developments.

AcuMedSpa Holdings, Inc. (OTC:AMSZ) is pleased to announce that it has reached an agreement with Santa Barbara Medical Innovations (SBMI) to become a preferred provider of the popular Zerona protocol which is a proven, non-invasive cold laser solution for unwanted body fat as well as for body slimming and contouring. Zerona has been featured in dozens of magazines and on TV shows such as "Rachael Ray," "Extra" and "The Doctors."

Advanced Life Sciences Holdings, Inc. (OTC:ADLS), announced it will host a conference call and webcast discussing the Company's 2009 third quarter results on Tuesday, November 10, 2009 at 10:00 a.m. (EST).

InterMune, Inc. (Nasdaq:ITMN) announced it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).

Javelin Pharmaceuticals, Inc. (NYSE:JAV) announced its CEO, Martin J. Driscoll, and Stephen J. Tulipano, CFO, will host a conference call to discuss the Company's quarterly results for the period ending September 30, 2009.

Lannett Company, Inc. (NYSE:LCI), a manufacturer of generic pharmaceuticals, announced the company will release its fiscal 2010 first-quarter financial results on Monday, November 9, 2009.

Unilife Medical Solutions Limited (OTC:UNIFF) (Unilife Australia) entered into a Merger Implementation Agreement with Unilife Corporation (Unilife USA) to facilitate the proposed redomiciliation of the Unilife group in the United States of America (Proposed Transaction).

Aeolus Pharmaceuticals, Inc. (OTC:AOLS) reported researchers from National Jewish Health and McGill University have completed a series of preliminary studies demonstrating that AEOL 10150 protects lungs from chlorine gas exposure in mice.

Pro-Pharmaceuticals, Inc. (OTC:PRWP) announced it has closed a $310,000 tranche of a private placement of up to $6.0 million with 10X Fund, L.P., which is purchasing unregistered Series B convertible preferred stock and warrants.

Affymax, Inc. (Nasdaq:AFFY) and Takeda Pharmaceutical Global Research & Development Center, Inc., announced data from a Phase 2 clinical trial of Hematide™ showing that Hematide increased hemoglobin and reduced or eliminated the need for blood transfusion in most patients with erythropoietin-induced pure red cell aplasia (PRCA).

Alkermes, Inc. (NASDAQ:ALKS) announced its corporate presentation will be webcast live by Credit Suisse on Wednesday, November 11, 2009, at 5:00 p.m MT (7:00 p.m. ET) from the Arizona Biltmore Hotel in Phoenix, Arizona.

Flamel Technologies (Nasdaq:FLML) expects to release its financial results for the third quarter of 2009 the morning of November 16th, before the market opening.

Neurogen Corporation (NASDAQ:NRGN), a drug development company, announced it will release its third quarter 2009 financial results on Friday, November 6, 2009 before the opening of the U.S. financial markets.

Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, reported financial and operating results for the quarter ended September 30, 2009.

Genta Incorporated (OTC:GETA) announced the Company will release its third quarter 2009 financial results on Monday, November 16, 2009.

Gilead Sciences, Inc. (Nasdaq:GILD) announced its corporate presentation will be webcast from the 18th Annual Credit Suisse Healthcare Conference in Phoenix.

SurModics, Inc. (Nasdaq:SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, reported financial results for the fourth quarter and fiscal year ended September 30, 2009.

"With high-quality stocks on sale, now seems an opportune time to look for bargains among small and midcap blue chips," suggests Richard Moroney.

In his Upside Stocks advisory, which uses the quantitative-based Quadrix ratings system, he says, "We've found several 'Best Buys' with superior year-ahead potential." Here, he looks at Aeropostale (NYSE: ARO), Catalyst Health (NASDAQ: CHSI) and Hornbeck Offshore (NYSE: HOS).

"Aeropostale, helped by consistent double-digit sales growth, has met or exceeded the consensus profit estimate in each of the past eight quarters.

"A specialty retailer focused on apparel and accessories for teenagers, Aeropostale operates more than 900 stores in the U.S., Puerto Rico, and Canada.

"Aeropostale has grown same-store sales for the past 11 fiscal years, including an 8% gain in the fiscal year ended January.

"Same-store sales have accelerated in the past couple of months, up 20% in April and 19% in May. Total sales rose 30% to $133 million in May.

"The company opened in June its first 'P.S. from Aeropostale” store, a new venture aimed at children aged 7 to 12.

"The kids’ apparel market is worth about $14 billion, and Aeropostale hopes to tap the pent-up demand of youths who model their tastes after older siblings. 

"Management plans to open another nine P.S. stores by January — and sees potential for up to 500 stores eventually. Aeropostale is a Best Buy.

"As a pharmacy-benefit manager, Catalyst Health Solutions helps lower prescription costs for clients by purchasing drugs in bulk.

"Two other drivers key Catalyst’s profitability: generic-drug usage and mail-order penetration. Both rose in 2008 as the poor economy gave clients new incentives to cut expenses.

"Catalyst has delivered highly predictable growth. Revenue has increased by at least 33% in the each of the last nine years. Per-share profits have climbed in 23 of the past 25 quarters, rising an average of 39% in that time.

"In May, Catalyst reaffirmed 2009 profit guidance of at least $1.35 per share, implying growth of at least 16%. Consensus estimates project per-share earnings will grow 21% in 2009 and 18% in 2010. 

"Looking further out, U.S. spending on prescriptions is expected to accelerate in the next few years in comparison to other health-care areas.

"The stock looks attractively priced at 16 times expected year-ahead earnings, a steep discount to the five-year average of 25. Catalyst is a Best Buy.

"Hornbeck Offshore provides oil companies with offshore supply vessels (OSVs) that haul cargo such as diesel fuel and dry bulk cement between coastal bases and offshore rigs. 

"These upstream operations represented 78% of revenue and 92% of operating income in 2008. Downstream operations include tugs and barges that transport petroleum products. Last year, Hornbeck hinted that it might sell the tug and barge business.

"The stock has been volatile, retreating 31% since June 1 but still up 29% in 2009. Natural gas prices remain depressed, and many worry about weak demand from gas-oriented operators in the Gulf of Mexico.

"But the stock, trading at less than seven times the lowest Wall Street estimate for 2010 earnings, appears to reflect such concerns.

"Hornbeck has posted a positive earnings surprise in the past three quarters. The company expects per-share profits of $3.50 to $3.97 in 2009, below last year’s $4.15.

"But the consensus estimate hovers at the low end of guidance, giving Hornbeck space to surprise Wall Street again. Hornbeck is a Best Buy."